KFAS
ACHV icon

Keating Financial Advisory Services’s Achieve Life Sciences ACHV Stock Holding History

Keating Financial Advisory Services’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Hold
24,911
– – 0.02% 390
2026
Q1 		$73.2K Hold
24,911
– – 0.01% 536
2025
Q4 		$124K Buy
+24,911
New +$109K 0.02% 455

Other funds holding ACHV

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Keating Financial Advisory Services's ACHV Position: Q2 2026 in Review

Keating Financial Advisory Services held its Achieve Life Sciences (ACHV) position steady in Q2 2026 at 24,911 shares worth $163K. The position accounts for 0.02% of the portfolio, ranked #390.

Keating Financial Advisory Services first reported a position in ACHV in Q4 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Keating Financial Advisory Services held 24,911 shares of Achieve Life Sciences worth $163K as of Q2 2026.
  • Keating Financial Advisory Services left its Achieve Life Sciences share count unchanged in Q2 2026.
  • Achieve Life Sciences made up 0.02% of Keating Financial Advisory Services's portfolio in Q2 2026, its #390 holding.
  • Keating Financial Advisory Services first reported a position in Achieve Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.